HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefan Janssens Selected Research

Intercellular Signaling Peptides and Proteins (Growth Factors)

8/2017Sustained Placental Growth Factor-2 Treatment Does Not Aggravate Advanced Atherosclerosis in Ischemic Cardiomyopathy.
1/2016Placental growth factor 2--A potential therapeutic strategy for chronic myocardial ischemia.
3/2013Placental growth factor increases regional myocardial blood flow and contractile function in chronic myocardial ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefan Janssens Research Topics

Disease

24Heart Failure
10/2022 - 02/2009
16Myocardial Infarction
01/2021 - 05/2004
13Infarction (Infarctions)
09/2018 - 01/2006
8Cardiomyopathies (Cardiomyopathy)
01/2022 - 03/2008
7Myocardial Ischemia (Ischemic Heart Diseases)
06/2017 - 05/2005
5Stroke (Strokes)
10/2022 - 06/2013
5Inflammation (Inflammations)
01/2022 - 10/2002
5Heart Diseases (Heart Disease)
01/2022 - 08/2014
5Left Ventricular Dysfunction
12/2019 - 01/2006
5Hypertension (High Blood Pressure)
12/2017 - 07/2008
5Atherosclerosis
08/2017 - 08/2002
4Neoplasms (Cancer)
10/2022 - 11/2005
4Cardiotoxicity
01/2022 - 06/2012
4Diabetes Mellitus
01/2021 - 06/2013
4Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 06/2006
4Ventricular Remodeling
01/2019 - 07/2007
4ST Elevation Myocardial Infarction
04/2014 - 01/2006
4Neointima
08/2009 - 06/2002
3Cardiogenic Shock
01/2022 - 09/2003
3Fibrosis (Cirrhosis)
01/2021 - 08/2005
3Cicatrix (Scar)
01/2021 - 03/2008
3Heart Arrest (Cardiac Arrest)
01/2020 - 01/2009
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 10/2002
3Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2018 - 06/2011
3Pulmonary Hypertension
01/2018 - 04/2006
3Obesity
01/2017 - 12/2009
3Hypoxia (Hypoxemia)
04/2008 - 04/2006
3Pathologic Constriction (Stenosis)
12/2007 - 06/2002
2Acute Coronary Syndrome
10/2022 - 01/2018
2Venous Thrombosis (Deep-Vein Thrombosis)
03/2022 - 06/2021
2Atrial Fibrillation
01/2022 - 05/2013
2Pathologic Processes
01/2022 - 01/2022
2Chronic Renal Insufficiency
01/2020 - 01/2019
2Type 2 Diabetes Mellitus (MODY)
01/2020 - 06/2013
2Aortic Valve Stenosis (Aortic Stenosis)
12/2018 - 09/2013
2Pulmonary Arterial Hypertension
12/2017 - 02/2014
2Hypertrophy
09/2014 - 05/2004
2Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2013 - 07/2012
2Weight Loss (Weight Reduction)
07/2012 - 12/2009
2Vascular System Injuries
08/2009 - 02/2006
2Vascular Remodeling
08/2007 - 04/2006
2Hypercholesterolemia
10/2002 - 08/2002
1Transient Ischemic Attack
10/2022
1Heart Valve Diseases (Valvular Heart Disease)
10/2022
1Myocarditis (Carditis)
10/2022
1Optic Nerve Diseases (Optic Neuropathy)
08/2022
1Open-Angle Glaucoma (Glaucoma, Open Angle)
08/2022
1Glaucoma
08/2022
1COVID-19
03/2022
1Critical Illness (Critically Ill)
01/2022
1Hypotension (Low Blood Pressure)
10/2021
1Urinary Tract Infections (Urinary Tract Infection)
10/2021

Drug/Important Bio-Agent (IBA)

9Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2017 - 05/2004
7Biomarkers (Surrogate Marker)IBA
11/2020 - 06/2008
6CollagenIBA
01/2022 - 08/2002
6Nitric Oxide Synthase (NO Synthase)IBA
12/2017 - 05/2004
4Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2002
4Guanosine Monophosphate (5' Guanylic Acid)IBA
12/2021 - 06/2002
4sacubitril and valsartan sodium hydrate drug combinationIBA
11/2021 - 01/2018
4empagliflozinIBA
11/2021 - 10/2020
4C-Reactive ProteinIBA
06/2021 - 10/2002
4Pharmaceutical PreparationsIBA
04/2018 - 01/2011
3omega-Chloroacetophenone (Mace)IBA
10/2022 - 01/2020
3Vasodilator Agents (Vasodilators)IBA
12/2021 - 08/2007
3Sodium-Glucose Transport ProteinsIBA
11/2021 - 10/2020
3RNA (Ribonucleic Acid)IBA
11/2020 - 01/2019
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2017 - 03/2013
3CholesterolIBA
08/2017 - 08/2002
2Peptides (Polypeptides)IBA
01/2022 - 01/2018
2DiureticsIBA
01/2022 - 01/2018
2Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 12/2007
2Neprilysin (Neutral Endopeptidase)IBA
11/2021 - 01/2018
2Green Fluorescent ProteinsIBA
11/2020 - 04/2008
2paragonIBA
11/2020 - 01/2018
2Messenger RNA (mRNA)IBA
01/2019 - 08/2005
2AntibodiesIBA
01/2018 - 01/2012
2Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
12/2017 - 02/2014
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2017 - 06/2012
2Electron Transport Complex IV (Cytochrome c Oxidase)IBA
01/2017 - 12/2016
2Troponin IIBA
01/2015 - 10/2007
2DobutamineFDA LinkGeneric
01/2013 - 08/2002
2GadoliniumIBA
10/2012 - 10/2010
2erucylphosphocholineIBA
05/2010 - 04/2008
2oxidized low density lipoproteinIBA
10/2002 - 08/2002
1Immune Checkpoint InhibitorsIBA
10/2022
13,5-diisopropylsalicylic acid (DIPS)IBA
08/2022
1vinyltriethoxysilane (VTES)IBA
03/2022
1Factor Xa (Coagulation Factor Xa)IBA
01/2022
1antineoplaston A10 (A 10)IBA
01/2022
1Digoxin (Digitek)FDA LinkGeneric
01/2022
1Mineralocorticoid Receptor AntagonistsIBA
01/2022
1fibrin fragment D (D-dimer)IBA
06/2021

Therapy/Procedure

24Therapeutics
01/2022 - 01/2006
4Stents
01/2016 - 06/2002
3Ligation
08/2017 - 08/2009
2Heart-Assist Devices
01/2022 - 01/2021
2Resuscitation
01/2020 - 01/2009
2Denervation
12/2017 - 01/2014
2Percutaneous Coronary Intervention
04/2014 - 01/2006
2Drug Therapy (Chemotherapy)
06/2012 - 05/2005